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Abstract
Pharmaceutical residues can reach agricultural land through amendment with animal or
human waste. Since 2010, a series of replicated plots received annual applications of
ivermectin, monensin and zinc bacitracin, either singly or in a mixture, at 0.1 mg/kg and 10
mg/kg concentrations. I collected soil samples before and after the fourth annual application
of pharmaceuticals and assayed them for functional changes and amoA gene abundance, a
gene needed for ammonia oxidation. In 2013, I exposed the soils to 100 mg/kg in a
laboratory experiment which resulted in acceleration of nitrification. Under 10 mg/kg
treatments in the field the abundance of ammonia-oxidizing bacteria was suppressed, while
ammonia-oxidizing archaea increased, suggesting that bacteria are more sensitive to these
pharmaceuticals, and that archaea can expand to occupy the partially vacated niche. None of
the pharmaceuticals at the guideline level of 0.1 mg/kg had any effect on soil function or
ammonia oxidizing organisms.
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1. Introduction

1.1. Soil: composition and function

Soils have specific physical and chemical characteristics, such as particle size and
composition, organic matter content, diffused gases (e.g. O2 and CO2), pH, temperature,
and water content (Tate III 2000). The combination of these factors can create favorable
or adverse conditions for life. Unfavorable conditions can prevent plant life, however
even small amount of nutrient allows for microbial growth. Microorganisms are very
good at adapting their environments to their needs, and can modify the physical and
chemical properties of soil, making it possible for them to thrive under conditions that
would be stressful for other life forms, including plants (Paul and Clark 1989).
Soil is organized vertically in layers, called horizons, with the top layer generally
being the most recent, while deeper layers represent further past (Tate III 2000). The
most studied layers are the “O” (top organic layer, most pronounced in forest soils due to
accumulating leaves and foliage), “A”, and “B” layers (underneath). The “A” layer
houses the greatest diversity and abundance of soil dwelling macro- and microorganisms,
which decline in the “B” layer (Tate III 2000). Most non-forest soils have little organic
matter present (>5%), and carbon and nitrogen are present in their mineral form; they are
called mineral soils because of this high mineral content (Tate III 2000). Mineral soils
can be classified based on the size of soil particles (sand, silt, clay), which facilitates
inter-study comparisons (Soil textural triangle, http://www.nrcs.usda.gov). Most soils in
Southwestern Ontario, Canada originated from material deposited during last glacial
retreat, and contains high proportion of mineral matter (Tate III 2000). The majority of
the land in this region has been used for agricultural purposes.
The physical and chemical elements of soil are modified by the biota present, which
promotes community growth and development, resulting in the formation of
interconnected trophic networks (Scharriba et al. 2012). Soil contains macro- (>2mm),
meso- (0.1-2mm) and microorganisms (<0.1mm) which contribute to soil physical
structure and function (Griffiths 1965). The total number of microorganisms living in soil
is not known, but it is estimated at 40 million cells per gram forest soil (Whitman et al.
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1998). All soil dwelling organisms contribute to soil functions such as decomposition of
organic matter and nutrient turnover (Griffiths 1964). Soil macroorganisms include small
soil dwelling animals such as earthworms, millipedes, beetles, and ants, that move
through the soil column and mix it while they graze on microorganisms or
mesoorganisms (Paul and Clark 1989). Mesoorganisms such as Collembola, mites, and
nematodes migrate through soil feeding on decaying matter and microorganisms. Their
movement disturbs soil particles, it may expose new nutrients and allows gases and water
to mix in the soil column. Microorganisms can take advantage of these new conditions to
proliferate. Bacteria and fungi are primarily responsible for breaking down dead plant
matter and other microorganisms are responsible for various steps in nutrient cycling
(Paul and Clark 1989, Tate III 2000).

1.2. Carbon and nitrogen in soils

Microorganisms in soil are considered the natural agents for human and animal
organic waste disposal (Paul and Clark 1989), because of their ability to recycle carbon
(C) and nitrogen (N) bound in organic matter. They break the nitrogen and carbon into
mineral C and N that can enter the soil nutrient pool, which is very important for
microorganism proliferation and plant growth. Together with carbon, other nutrients and
trace minerals are released during decomposition for use by soil organisms and plants.
Carbon exists in the gaseous form in the air (as CO2), and is incorporated into the
soil ecosystem through CO2 uptake by plants and bacteria (Hutchinson et al. 2007) and
subsequent incorporation (immobilization) into living tissues. Once carbon is bound in
the organic form, it remains there until the tissue dies, at which point C is recycled
through the decomposition of dead tissues by soil decomposing organisms. Carbon can
be stored in organic form in tissues for extended periods of time, especially if the species
is long lived one. Even after tissue death, carbon can be trapped in the organic form, due
to different levels of degradability of plant material (Terry et at. 1979). Materials such as
starches are readily hydrolyzed and used by soil microorganisms, while molecules like
cellulose, lignins, and keratins are only partially decomposed (Attiwill 1986, Tate III
2000) due to their strong molecular bonds.
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Fungi and bacteria living in the soil are the major contributors to organic matter
decomposition, and they breakdown organic matter into simpler molecules that are
accessible to plants and other microorganisms. Dissipation (oxidation of organic matter)
generates energy that microorganisms use for growth. During the process of energy
production, soil microorganisms use molecular O2 as an electron acceptor and yield CO2
and H2O. The amount of CO2 released is proportional to the amount of degraded matter;
therefore the rate of microbial decomposition is traceable by monitoring the CO2 emitted
from the soil (Lehmann and Miller 1999). About 70% of plant residue added to soils is
degraded, while the remainder is incorporated into microbial biomass, or remains
undegraded (Tate III 2000).
Nitrogen is abundant in the environment, but most of it exists in the atmosphere in
the form of nitrogen gas (N2). Itis only accessible to a small number of organisms
(nitrogen fixing microorganisms), which add it to the nitrogen pool in the soil (Equation
1). Dead plant matter also contains nitrogen that is released during decomposition. The
soil nitrogen pool therefore consists of nitrogen from N 2 fixation and N obtained through
decomposition of plant matter, or in the case of managed agricultural land from fertilizer.
Decomposers (fungi and bacteria) use tissue-bound N, mineralize it into ammonia (NH3),
and release it into the soil N pool, making it accessible to other organisms. Ammonia
present in the soil is converted to ammonium (NH4+, the protonated form of ammonia) at
typical soil pH values. Ammonium is converted to nitrite (first step of nitrification) by
ammonia-oxidizing organisms. Nitrification is initiated by the insertion of an atom of
oxygen into ammonia by the ammonia monooxygenase (AMO) enzyme. Further
oxidation by hydroxylamine oxidoreductase results in nitrite (McTavish et al. 1993,
Vajrala et al. 2013). Nitrite is quickly converted to nitrate by nitrifying bacteria, and
readily used by plants. This form is easily converted back to N 2 by denitrifying organisms
(Ellis et al. 1996), or lost to the environment through runoff from the soil surface or
leaching to the ground water (Friedland et al. 1997).
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Equation 1. Simplified nitrogen cycle in soil

1.3. Ammonia oxidizing (AO) organisms

The conversion of soil ammonium to nitrite is catalyzed by a very narrow range of
organisms called ammonia oxidizers (AO), which use ammonia as their only energy
source (Stein et al. 2012). The ammonia-oxidizing microorganisms can be distinguished
from other soil microorganisms through molecular analysis of the amoA genes, which
encode the ammonia monooxygenase (AMO) enzyme. Two groups of microorganisms in
soils, bacteria and archaea, possess AMO and are capable of converting NH 4+ to nitrite
(Rotthauwe et al. 1997, Francis et al. 2005). Both ammonia oxidizing bacteria (AOB) and
ammonia oxidizing archaea (AOA) are active in soils. It is well established through amoA
gene counts in soil that AOA dominate in NH4+ limited environments that contain high
concentrations of organic nitrogen, while AOB thrive in nitrogen rich ecosystems such
as agricultural land after fertilizer addition (Stein et al. 2012, Sonthiphand et al. 2013).
The individual contributions of AOA and AOB to soil nitrification are however largely
unknown. These organisms are difficult to culture in the laboratory, with only a few
representatives having been described (Tourna et al. 2008, Martens-Habbena et al. 2009).
The difficulty in isolating and cultivating these soil microorganisms might be due to their
diverse nutritional needs, their need for coexistence with other organisms, or other
conditions that cannot yet be recreated in the laboratory.

1.4. Unmanaged vs. managed (agricultural) soils

Ammonia-oxidizing archaea are usually more abundant than ammonia-oxidizing
bacteria in cultivated soils (Leininger et al. 2006, Adair and Schwartz 2008, Tourna et al.
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2008, O'Sullivan et al. 2011, Dias et al. 2012, Taylor et al. 2013). The cultivation of soil
for crop production creates annual cycles of disturbances that might be responsible for
the differences between the distributions of AOA and AOB organisms in unmanaged
versus managed soils. In unmanaged soils, plant and animal remains decompose in situ to
release nutrients (such as C and N) that other organisms can use. However, in the
agricultural context, plant residues are rarely returned for decomposition and nutrient
cycling, and nutrients are exported in the harvested crop. The nitrogen is depleted readily
and needs to be replenished through fertilization before the next crop is planted (Vitousek
et al. 1997, Edmeades 2003, Galloway et al. 2004). When inorganic nitrogen fertilizer is
added to soil, plants and microorganisms compete for that nitrogen (Inselsbacher et al.
2010). While microorganisms are better than plants at acquiring ammonia in the first
hours after fertilizer addition, plants are better at holding on to N due to their longer
turnover rates (Schimel and Bennett 2004). Therefore, the majority of fertilizer applied to
fields is used by crops and subsequently removed from the site.
In Ontario it is common practice to apply animal waste (manure) or human waste
(biosolids) as fertilizer on agricultural fields. The re-use of otherwise wasted material is
economically important, because it provides a quick and easy way of disposal of farm
animal and human waste, and it saves landfill space, while providing a source of N to
crops. The manure and biosolids contain organic nitrogen, which is not readily accessible
to plants and needs to be mineralized by soil microorganisms into inorganic nitrogen.
These amendments also contain phosphate and potassium, and they increases soil texture
and water holding capacity (Eldridge et al. 2008).

1.5. Risk of applying manure and biosolids to agricultural fields

Despite the potential economic gains of using soil amendments, the potential impacts
of applying waste material to fields need to be carefully considered. The land application
of municipal biosolids (organic material recycled from sewage) and manures from
medicated animals introduces veterinary and human pharmaceuticals, endocrine-active
substances and personal care products into soil (Thiele-Bruhn 2003, Lorenzen et al. 2004,
Borgmann et al. 2007, Sabourin et al. 2012). In manure, the type and amounts of

6
veterinary pharmaceuticals introduced at the moment of land application varies according
to what is permitted for use in a given production system, the health status of the animals,
and how the manure is stored and handled prior to application (Pope et al. 2009).
Antimicrobial pharmaceuticals are designed to work well in very small concentrations
on the bacterial and parasitic organisms that attack livestock (Kumar et al. 2005, Toth et
al. 2011, Jechalke et al. 2014). They are often excreted in their unchanged bioactive
forms (Al-Ahmad et al. 1999, Thiele-Bruhn 2003, Sarmah et al. 2006), and thus manures
can contain veterinary pharmaceuticals, including parasiticides and antimicrobial agents
used for prophylaxis or therapy and for growth promotion (HC 2001, Sarmah et al. 2006,
Liebig et al. 2010b). Because the majority of the pharmaceuticals excreted by medicated
animals are still in their active form, they can negatively affect the soil bacteria that come
in contact with them, with potential negative effects on N processing in soil. Manures
typically contain pharmaceuticals in combination, and therefore mixture toxicity effects
are of scientific and regulatory concern (Kemper 2008, van Gestel 2012, Altenburger et
al. 2013). Among the possible mixture effects (additive, no effect, synergistic) the most
concern centers on the synergistic effects of these compounds (multiplication of the
effects of a single pharmaceutical). Singly the pharmaceuticals can be present at levels
too low to be toxic, but combined and multiplied, the effects can be detrimental to soil
microorganisms, and their services in soil.
Pollution with pharmaceuticals can have long term effects on soil organisms, but
in heavily polluted environments soil microorganisms can become tolerant of the
pollution, at a community scale (Schmitt et al. 2004). This response is called pollutioninduced community tolerance (PICT) and it results from more tolerant organisms
multiplying and replacing the more susceptible organisms. This resulted in a change in
community structure, and sometimes soil function (Nannipieri et al. 2003, Schmitt et al.
2004, Demoling and Baath 2008, Aaen et al. 2011). The difference between susceptibility
and tolerance of organisms can be due to intrinsic resistance, ability to tolerate low
concentrations of pharmaceuticals, structural differences preventing negative effects of
pharmaceuticals; or acquired resistance through acquiring resistance genes from other
microorganisms or the environment. In the case of ammonia oxidizing organisms,
bacteria and archaea are structurally distinct from one another; therefore it is possible that
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the pharmaceuticals designed to target bacterial infections in farm animals may not
necessarily affect archaea in the same way. Archaea have a different cell wall structure,
biochemical pathways, and enzymatic activity from bacteria (Schleper and Nicol 2010)
although not much is known about the soil achaea due to the difficulty in cultivating the
organisms (only one soil AOA organisms has been cultivated in the laboratory; MartensHabbena et al. 2009).

1.6. Regulations surrounding use of veterinary pharmaceuticals

The degree to which each new pharmaceutical is tested before approval depends
on its predicted environmental concentration (PEC). The predicted level of
pharmaceuticals reaching the environment is tested against a tiered environmental risk
assessment (ERA), where the no effect concentration level is set as 0.1 ppm (1 parts per
million is equal to 1 mg pharmaceutical per kg soil). A concentration of 0.1 ppm is the
International Co-operation on Harmonization of Technical Requirements for Registration
of Veterinary Medicinal Products (VICH; http://www.vichsec.org) trigger value, and
indicates the conservative cut-off amount of pharmaceutical in the environment expected
to cause no detectable negative effects (NOEC = no observable effect concentration) on
soil organisms or processes (VICH 2000, Montforts 2005, Schmitt et al. 2010) (overview
of Canadian participation in VICH can be found at http://www.hc-sc.gc.ca/dhpmps/vet/legislation/guide-ld/vich/index-eng.php).

High

loads

of

pharmaceuticals

administered to animals can lead to increases in the amount of pharmaceuticals present in
the manure.
If the PEC present in the soil treated with manure is below the VICH trigger
value, no further tests are required for the specified pharmaceutical. However, if the
amount expected, or already present exceeds 0.1 ppm, it triggers a Phase II of ERA,
requiring additional soil fate studies on non-target species (Van Den Brink et al. 2005,
VICH 2005, Tarazona et al. 2010). These are specified one-species tests measuring the
lethality of the pharmaceutical, taking into account such endpoints as mortality,
development, and reproduction (species used and corresponding OCED regulations
summarized in (van Gestel 2012)). Soil incubations (microcosms) measuring functional
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endpoints (such as mineralization or nitrification) are also used to monitor the microbial
responses to pharmaceuticals (Van Beelen and Doelman 1997, OECD 2000, ISO 2012).
The use of soil incubation experiments for functional toxicity studies can be coupled with
molecular analysis (for example qPCR, quantitive polymerase chain reaction; PCRDGGE, PCR based denaturating gradient gel electrophoresis, and others) as an indicator
of the effects of these pharmaceuticals on the abundance and community structure of soil
microorganisms (OEHHA 2009).

1.7. Studied pharmaceuticals and their uses

Three pharmaceuticals commonly used to treat farm animals in North America
that were chosen for my study are monensin (MON), ivermectin (IVER), and zinc
bacitracin (ZBAC). All three of these pharmaceuticals have different modes of action,
and potentially different target organisms in soil (Table 1). Both IVER and MON are
isolated from soil Streptomyces species (S. avermitilis and S. cinnamoniensis,
respectively), while ZBAC is isolated from Bacillus species (B. subtilis, and B.
licheniformis). While IVER and MON have bactericidal properties on their own, ZBAC
needs to be bound to a metal ion to show bactericidal activity (Ming and Epperson 2002).
Given that these pharmaceuticals originate from soil dwelling microorganisms, it is
expected that resistance or tolerance to these compounds already exist at low levels in the
environment (D'Costa et al. 2011, Bernier and Surette 2013) and this resistance can
spread under heavy pharmaceutical applications.
Ivermectin (IVER) is a broad spectrum antiparasitic pharmaceutical, used to kill
ecto- and endoparasitic infections in sheep, cattle, and pigs. Ivermectin is excreted
primarily in faeces (Beynon 2012) as a parent (unchanged and active) pharmaceutical
(Halley et al. 1989, Eržen et al. 2005). A negative effect on non-target invertebrate soil
species was reported for IVER shortly after its widespread use. The negative effect was
confirmed during single species toxicity testing in the laboratory and field
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Table 1. Studied pharmaceuticals and their properties
Ivermectin

Monensin

Zinc bacitracin

formula

C48H74O14

C36H61O11 Na

C66H101N17O16Zn

melting point

155 °C

269°C

250 ºC

Solubility
(solvent)

50 g/L (2-butanone)

50 g/L (methanol)

5.1 g/L (water)

action

antiparasitic

bactericidal

bactericidal

structure
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(Liebig et al. 2010b, O'Hea et al. 2010, Blanckenhorn et al. 2013), where IVER was
shown to cause mortality (at 5ppm) and reduce reproduction (at 0.02ppm) in soil
invertebrates (Jensen et al. 2009).
Monensin (MON) is an ionophore antibiotic (i.e. disrupts ion transport through
membranes), with antiparasitic properties and it is commonly used in cattle and poultry
for growth promotion and prevention of bacterial infections. It is excreted in its active
form in faeces (Donoho 1984, Sassman and Lee 2007). Following the ban of
pharmaceuticals as growth promoters in the European Union (UN) in 2006 (EC 2003), its
use is mainly in North America. MON has reduced reproduction of soil invertebrates, but
at a much higher level (100ppm) than IVER (Jensen et al. 2009).
Zinc bacitracin (ZBAC) is in its biologically active form as a complex of the
heavy metal zinc and the antibiotic bacitracin (Ming and Epperson 2002). It is used in
poultry and swine as a growth promoter. It acts by disrupting cell wall synthesis
(preventing cross linking of peptidoglycans, which are numerous in the cell wall of gram
positive bacteria but absent in eukaryotic cells). Similar to IVER and NON, it is found in
its active form in animal manure (Donoso et al. 1970). When zinc is released from
bacitracin (Drabløs et al. 1999) it can be considered a secondary contaminant in the soil
treated with ZBAC. Metal pollution was shown to disrupt community function in soils
with high levels of heavy metals such as copper and zinc (Mertens et al. 2010, Ruyters et
al. 2013), and it can cause a PICT response in soil communities (Baath et al. 1998).

1.8. Microcosm incubations

Microcosms represent a community, place or situation that represents a miniature
of something much larger, but encapsulating its characteristic qualities or features.
Laboratory constructed microcosms are open or closed simplified ecosystems containing
living organisms assembled in a simplified environment (Huhta 2006). Their function is
to study processes that drive population and ecosystem ecology, but in a laboratory
setting, with the intention that the results can then be extrapolated to the outside
environment. In microcosms one has precise control over abiotic variables, and the
manipulation of a single parameter is possible, while keeping other factors constant.
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Microcosms are short term and therefore require less resources; however, due to space
restrictions they can sometimes over-simplify the natural world, and extrapolation of the
results therefore can be difficult (Fraser and Keddy 1997, Browder 2004, Drake and
Kramer 2012). However, the ease of use of these simplified systems makes them useful
tools for studying natural processes.
In studies of pharmaceutical toxicity in soils, microcosms are used to determine
functional changes. The pharmaceuticals are added to determine the effects they have on
the measured parameters (Lehmann and Miller 1999, Offre et al. 2009). For
pharmaceutical dissipation tests, the dissipation of a studied pharmaceutical is monitored
over time (Girardi et al. 2011).

1.9. Objectives and hypothesis

In the present study, I examined effects of the antiparasitic IVER and the antibiotics
MON and ZBAC both singly and combination (MIX), using functional assays
(mineralization and nitrification in soils) and molecular techniques (amoA gene
abundance and structure of AOA and AOB communities). I hypothesized that the studied
pharmaceuticals would affect the abundance of soil microorganisms and functions they
carry out in the soil. Therefore, I predicted that: 1. Increasing exposure concentrations
(0.1, 10, and 100 ppm) will have an increasingly negative effect on function and AO
community structure. 2. Pharmaceuticals will cause a negative effect shortly after
addition to soils, but no long term effect will be present (the community will recover
from the disturbance, returning to the pre-disturbance levels of function and abundance).
3. In mixture, single pharmaceutical effects will multiply to exert a synergistic effect on
the function and structure of soil.
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2. Materials and Methods

2.1. Chemicals

Methanol, 2-butanone, formamide, IVER, MON sodium salt, and ZBAC salt were
purchased from Sigma-Aldrich (Toronto, ON). Stock solutions of IVER, MON and
ZBAC were prepared fresh before addition to soil using 2-butanone, methanol, and sterile
water, respectively.
Molecular reagents (PCR, qPCR, and cloning reagents) were purchased from
Agilent Technologies (Toronto). Primers were ordered from Sigma-Genosys (Toronto),
and diluted to 10 μM with Tris buffer (Agilent Technologies). TAE buffer, 40%
acrylamide and urea for DGGE analysis were purchased from BioRad Laboratories
(Toronto). Radioactively labeled pharmaceuticals for dissipation studies were purchased
from American Radiolabeled Chemicals, Inc. (ARC, St Louis, MO).

2.2. Long term field experiment (addition of 0.1 and 10 mg/kg of
pharmaceuticals)

A long term field experiment to evaluate the effects of selected veterinary
pharmaceuticals on soil properties was undertaken on the Agriculture and Agri-Food
Canada research farm in London, Ontario (43°01'49.5"N, 81°12'23.8"W). The location
has a humid continental climate characteristic of much of the mid-Eastern coast of North
America and loam soils with low organic matter content (2-3%) and pH of 6.9-7.6. In
2010 the experiment was started, with the plots receiving pharmaceuticals that could
reach agricultural land through the application of animal manures or municipal biosolids,
including macrolide antibiotics, fluoroquinonole antibiotics, antiviral pharmaceuticals,
antimycotic agents, antineoplastic pharmaceuticals, and the pharmaceuticals evaluated in
the present study (IVER, MON, ZBAC).
The experimental procedures and field operations are described in Topp et al.
(2013). Briefly, a series of plots (2 m2, isolated by fiberglass frames) were treated every
spring since 2010 with two concentrations (0.1 mg/kg and 10 mg/kg) of IVER, MON, or
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ZBAC, and a mixture (MIX) of all three pharmaceuticals. Each year since 2010, the plots
have been treated annually in the spring (3 annual treatments applied prior to 2013
pharmaceutical application). Each treatment had four replicated plots organized in a
random block design, totaling 40 plots. One kilogram portions of soil were taken from
each plot, amended in the laboratory with appropriate concentrations of pharmaceuticals
according to the experimental protocol, brought out to the field, and incorporated into the
top 15 cm using a mechanized rototiller (sterilized with 70% ethanol between
treatments). Within 24 h of the pharmaceutical incorporation all plots were seeded with
soybean (Glycine max, variety: Harosoy). While the actual path the pharmaceuticals
reach agricultural fields is through manure application, the manure step was omitted in
this study to be able to eliminate potential confounding effects due to other chemical and
microbial constituents in manure.

2.2.1.

Soil sampling of field plots

Soils were sampled in May 2013 before the pharmaceutical addition (D0,
representing a long term effect of 3 years of annual applications of pharmaceuticals), and
in June 2013 at seven (D7) and thirty (D30) days after the addition of pharmaceuticals.
Additional sampling to validate the methods was done in fall 2012 (approximately 6
months following the 2012 pharmaceutical addition to the plots; referred to as “fall”
throughout this document).
At each of field sampling times, six soil cores (0-15 cm from the surface) were
taken from each of the replicate plots with a sterilized (70% ethanol) T-corer and mixed
together in a polyethylene bags. The samples were brought to the lab, sieved (2 mm
maximum particle size), and adjusted to 15% moisture with sterile water. The water level
in the sample was measured using MB45 Ohaus digital moisture analyzer (VWR,
Toronto, ON). All soils were processed within 24 hours of collection, except the D0 soils,
which were frozen at -20 ˚C prior to analysis. The sieved and moisture-adjusted field
soils were used in the microcosm incubation experiment to assess soil function.
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2.3. Short term laboratory experiment (addition of 100 mg/kg of pharmaceuticals)

Incubations were performed in the laboratory where control soil (i.e. never treated
with the studied pharmaceuticals) was treated with 100 mg/kg of each pharmaceutical
and their mixture in triplicate mason jars (500 g soil each). Several kilograms of soil was
sieved and adjusted to 15% moisture content. Five hundred gram portions of soil were
dispensed into a series of 1-L glass mason jars and amended with pharmaceuticals as
follows. Stock solutions were made using 1 mg of pharmaceutical in 10 ml of solvent.
Approximately one gram of soil was taken from each jar and placed into an aluminum
foil boat, and 250 µL of stock solution was added to the soil aliquot. The solvent was
allowed to evaporate for 10 minutes, after which the amended portion was mechanically
mixed with the rest of the soil for 5 minutes. Mason jars were sealed with a screw-cap lid,
and incubated at 30 oC. Every week the microcosms were opened for 5 minutes to allow
gas exchange. Seven days following pharmaceutical addition (high D7) half the soil was
removed from each microcosm for functional analysis and DNA extraction for molecular
analysis. Following 30 days of incubation (high D30) the remaining soil was taken and
the incubation terminated. A scintillation vial containing 10 mL of water was placed in
each microcosm. Soil not used in experiments was frozen at -20 ⁰C.

2.4. Functional assays

The Organization for Economic Co-operation and Development guidelines
(OECD 2000) lists mineralization and nitrification as sensitive endpoints for soil toxicity
testing. Here, mineralization was measured in both the laboratory, using microcosms with
radioactively labeled plant material (Section 2.4.1), and in the field, using plant-based
bait lamina strips (Sec. 2.4.2). Nitrification was measured through microcosm incubation
and analysis of ammonium and nitrate extracted from the soil (Section 2.4.3). In this
study, microcosms consisted of a mason jar (8 cm diameter, 20 cm high), small jar
containing soil (4 cm diameter, 4 cm high), and vial of water (scintillation vial containing
10ml of water) to keep soil from drying. The lid on mason jar was tightly closed to
eliminate gas exchange with the outside.
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2.4.1.

Rye mineralization

Soils collected from field (fall, D0, D7, and D30) and laboratory (high D7, high
D30) were mixed with a known amount of 14C labeled plant material (“rye”, Secale
cereal) and placed in microcosms. The rye was grown in 2008 in a greenhouse, with
radiolabeled carbon (14CO2), which was incorporated into the plant tissues. The material
was harvested, dried and chopped, and was stored frozen at -80 °C. The amount of
radioactivity present in the plant material was determined by oxidation of triplicate 1 g
portions of the material (Biological Oxidizer OX-500, R.J. Harvey Instrument Co.,
Hillsdale, NJ).
Rye was mixed with 25 g soil (moist weight) to obtain 1 200 000 Bq per jar of
soil. Each small jar containing rye spiked soil was placed in a Mason jar with a
scintillation vial with water and a scintillation vial with an alkali trap (7 mL of 1 M
sodium hydroxide). The trap was exchanged on days 1, 3, 7, 14, 21, and 28. Ten mL of
scintillation liquid (“cocktail”, UniverSol™, MP Biomedicals, Montreal, QB) was added
to each extracted trap, shaken lightly, and counted 24 hours after trap extraction in a LS
6500 Multi-purpose Scintillation Counter (Beckman Coulter TM, USA).
The cocktail was needed to allow for counting of the captured radioactivity.
Namely, the solvent molecules reacted with β particles emitted from radioactive decay of
14

C to release UV light which, upon absorption by cocktail molecules, emitted blue light,

which was counted (cpm, counts per minute) with the liquid scintillation counter (LSC).
The LSC then corrected the cpm values to dpm (disintegrations per minute) based on
counting efficiency (Auto DMP counting method, one of the options programed into
LSC). The rate of 14C-CO2 production was calculated for each microcosm by plotting
cumulative 14C-CO2 production against microcosm incubation time up to 28 days and
fitting a curve to the data using Sigma Plot (Version 10, Systat Software Inc., Chicago,
IL).
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2.4.2.

Bait lamina

To test for a treatment effect on soil faunal activity, an experiment to evaluate the
decomposition of organic matter was conducted in situ in fall 2012 using bait lamina strip
tests (Terra Protecta GmbH, Berlin, Germany). The bait lamina strips were 10 cm × 0.5
cm × 0.01 cm, with 16 perforations spaced 0.5 cm apart and filled with a mixture called
‘bait’, containing plaster, activated coal and bran flakes (http://www.terraprotecta.de/englisch/ks-info-en.htm).
Ten bait strips were inserted vertically in the centre of each control and treated
plot (40 plots total) in two parallel lines (lines and individual strips spaced 10 cm apart).
The strips were oriented such that hole #1 was close to the surface, and hole #16 was the
deepest. To avoid bait loss during insertion, a guide hole was premade in the soil with a
metal tool of similar dimensions to the lamina strip, prior to the strip insertion.
The strips remained in the soil for 3 weeks, after which they were carefully pulled
out. If the soil was wet and obscured the view of the holes, the strip was gently dipped in
water to remove adhering soil while minimizing loss of the remaining bait (physical
wiping of the strip with paper towels could have dislodged the bait). The holes were
scored as active or inactive based on the amount of remaining bait (with bait pierced
through counted as active). Activity was measured as the total number of pierced holes
per treatment.

2.4.3.

Determination of nitrification potential

One hundred and thirty grams (wet weight) of field soils (fall, D0, D7, D30) and
laboratory soils (high D7, high D30) were placed in microcosms (see section 2.2.1) and
incubated at 30 ˚C for 28 days. Subsamples of 15 g (wet weight) were taken out on days
0, 1, 3, 5, 7, 14, and 28 and extracted for analysis of inorganic nitrogen species (Drury et
al., 2008). Briefly, 75 mL of 2 M KCl was added to the 15-g soil samples and shaken in
Nalgene bottles for 1 h on a wrist action shaker (Burrell Scientific, Model 75, Pittsburgh,
PA) at 385 rpm. Extracts were poured through GF/A grade microfiber filters
(Whatman™, VWR, Toronto, ON) under vacuum. The supernatants were collected in
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scintillation vials that were stored at -20 oC until colorimetric analysis for ammonium and
nitrate + nitrite. These nutrient analyses were performed using a SmartChem 140 discrete
auto-analyzer, (Westco Scientific Instruments, Brookfield, CT). During analysis. nitrate
was reduced to nitrite by passing it through an open tubular cadmium reductor (OTCR)
coil, which formed a colored dye upon reaction with N-(naphthyl)-ethylenediamine
dihydrochloride (SmartChem 140 Method 375-100E-2). The nitrite component present in
the soil samples was negligible, because nitrite only exists transiently in the soil.
Ammonium was quantified through reaction with phenol and hypochlorite to form
indophenol blue (USEPA Method 350.1).

2.5. Molecular methods.

In addition to functional assays, molecular methods were used to examine changes in
community composition in respect to the different pharmaceutical treatments. Changes in
total 16S rDNA and amoA genes were monitored. The genes were quantified using
qualitative methods and visualized using denaturing gradient gel electrophoresis, which
resolves DNA molecules of equal length on the basis of melting behavior.

2.5.1.

DNA extraction

DNA was extracted from 250 mg of soil (wet weight) using the PowerSoil DNA
extraction kit (MO BIO laboratories, Inc., VWR, Toronto) and quantified with a
Nanodrop 1000 instrument (ThermoScientific, Toronto, ON). Extracts (corresponding)
were diluted 10-fold to a final concentration of 1-2 ng DNA/μl with DNAse-free reagent
water (MO Bio Laboratories, Toronto, ON) and used as template in the PCR. For all of
the samples, the 10x dilution removed enough inhibitors to allow amplification when
used in the PCR reaction. Extracted and diluted DNA was stored at -20˚C until analysis.
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2.5.2.

Amplification of DNA

The polymerase chain reaction (PCR) was used for amplification of extracted
DNA with primers for total 16S rDNA (GM5F/907R, (Muyzer et al. 1993)), AOA
(Crenamo A23f/Crenamo A616r, (Tourna et al. 2008)) and AOB ((amoA1F/amoA 2R)
((Rotthauwe et al. 1997)).The 25 μl PCR reaction consisted of 5μl SYBR Green 5x
buffer, 1.5 μl MgCL2 (200 μM), 0.2 μl of dNTP (25μM), GoTaq Flexi Polymerase
(Thermo Fisher Scientific, Ottawa, ON), 1 μl of each primer (10 mM) and 2μl of 10 fold
diluted DNA sample, and remainder filled with molecular grade water. Five microliters
of PCR product was electrophoretically resolved on 1.5% agarose gel (70 min at 220V),
and stained with GelRed Nucleic Acid Stain (Cedarlane®, Burlington, ON) to confirm
the product was of the expected size. The primer information and conditions of the PCR
reactions are summarized in Table 2.

2.5.3.

Quantitative PCR

For quantitative analysis (qPCR) of total 16S rDNA, the BACT2 primer set
described previously (Suzuki et al. 2000) was used with 2x Brilliant SYBR® qPCR
Master Mix (Agilent Technologies, Toronto, ON). Reactions contained 12.5 μL buffer,
0.75uL of each primer (10 mM), 2uL of 10 fold diluted template DNA, and 0.75 μL
TM1389F

probe

(HEX-CTTGTACACACCGCCCGTC-BHQ1,

HEX:

2′,4′,5′,7′-

tetrachloro-6-carboxy-4,7-dichlorofluorescein succinimidyl ester; BHQ1: Black Hole
Quencher-1; 10 mM), and molecular grade water for a total of 25uL.
The abundance of amoA gene for AOA and AOB was determined with the
following primers: the AOB amoA -specific primers (amoA-1F/amoA-2R) used were the
same as in the PCR reaction (Rotthauwe et al. 1997). The AOA amoA-specific primers
(Cre374-F:

TAATTGGCGGAACATTGGTT,

and

Cre495-R:

CATGTATGGAGGCAATGTCG; Figure 1) were designed and validated in the present
study as described in Marti et al. (2014). Reactions contained 12.5 μL 2x Brilliant
SYBR® Green qPCR Master Mix (Agilent Technologies, Toronto, ON), 0.75 uL of
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Table 2. PCR primer information

Target

Primer pair

Conditions

Product size (bp)

Reference

Archaeal amoA

Crenamo A23f/Crenamo A616r

95o(10min), 95o (45s), 57o (60s),
72o (45s)x39cycles

620

Tourna et al.,
2008

Bacterial amoA

amoA1F/amoA-2R

95o (10min), 95o (45s), 55o (60s),
72o (45s)x39cycles

490

Rotthauwe
et al 1997

16S rDNA

GM5F/907R

95o (10min), 95o (15s), 59o (20s),
72o (40s)x39cycles

600

Muyzer et al
1993
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Figure 1. Standard curve for new archaeal amoA primers, Cre374-F/Cre495-R. Cq
represents the cycle that the amplified DNA reached a threshold quantity (between 0-40
cycles). The starting quantity corresponds to the known quantity of DNA from the
standard curve dilutions.
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each primer (10 mM), and 2 uL of 10 fold diluted template DNA, and molecular grade
water to bring the volume up to 25 uL. Standard curves were created using 10 fold
dilutions of plasmid containing 106 to 100 copies per well of archaeal or bacterial amoA
insert, or 16S rDNA insert. The plasmid was prepared by cloning PCR products into
competent E.coli cells using the StrataClone cloning kit (Agilent Technologies, Toronto,
ON), and linearized with NotI-HF™ restriction enzyme (New England BioLabs, Whitby,
ON). Qualitative PCR conditions and efficiency of the standard curve reactions
summarized in Table 3.
Melting curve analysis for amoA targets ranged from 65˚C to 95˚C and was added
at the end of the 40 cycles, and revealed a single product peak and low primer dimer
concentrations. Amplifications were performed with a CFX96 Real-Time System
(BioRad, Toronto, ON) and using the Biorad CFX manager v3.0. Each qPCR sample was
run in triplicate. Negative controls without DNA template were performed in triplicate
for each run. The amoA product of the qPCR reaction for the control and high mixture
treatments at D30 after pharmaceutical addition was sequenced in order to determine the
relationship between the two communities.

2.5.4.

PCR-DGGE method

Denaturing gradient gel electrophoresis (DGGE) analysis used PCR products of
amoA and 16S rDNA, with one modification: the bacterial forward primer had a 33 base
pair GC tail (Muyzer et al. 1993) added to the 5’ end. Fifteen microliters of the PCR
products were loaded directly (without purification) on to 6% polyacrylamide DGGE gel
(100% denaturing mixture consisted of 7M urea and 40% deionized formamide) of 5065%, 55-65%, and 35-50% for 16 rDNA, bacterial amoA and archaeal amoA,
respectively. Gels were run at 90 V in 60˚C 1xTris acetate EDTA (TAE) buffer for 16
hours , stained with SYBR Gold (nucleic acid stain, Life Technologies, Burlington, ON)
and visualized with Molecular Imager Gel Doc TM XR (BioRad, Toronto, ON). Dominant
bands were cut from the DGGE gel, cloned following a previously described protocol
(Section 2.3.3.) and sequenced.
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Table 3. Qualitative PCR primer information

Target

Archaeal amoA

Bacterial amoA
Bacterial 16S
rDNA

Primer pair

Cre374-F/Cre495-R

amoA1F/amoA-2R
BACT1369F/PROK1492R

Conditions
95o (600s), 95o (15s), 57o
(20s), 72o (40s)x39cycles,
65-95 melting curve
95o (600s), 95o (15s), 58o
(20s), 72o (40s)x39cycles,
65-95 melting curve
95o (600s), 95o (15s), 59o
(40s), 72o (40s)x39cycles

Efficiency

Product
size (bp)

Reference

97.6

122 this paper

92.9

490 Rotthauwe et al 1997

109

174 Suzuki et al., 2001
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2.5.5.

Cloning and sequencing of DNA products

The bacterial and archaeal amoA products of the qPCR reaction (control and 10
mg/kg mixture treatments at D30 after field pharmaceutical addition) were purified
(QIAquick PCR purification kit, Agilent Technologies, Toronto), and measured using a
Nanodrop 1000 instrument (ThermoScientific, Toronto, ON). The prepared DNA mix
was then used in a cloning procedure with competent E.coli cells using a StrataClone
cloning kit (Agilent Technologies, Toronto, ON). The colonies containing the desired
insert were picked and amplified to obtain a large quantity of DNA (between 45 and 60
ng/μL) to be sent for sequencing (Robarts, and on site sequencing). The resulting
sequences were then analyzed and graphed.

2.6. Pharmaceutical dissipation

Pharmaceutical dissipation experiments were conducted using control soils (never
treated with pharmaceuticals) that were sieved (2mm) and adjusted to 15% moisture. The
radioactively labeled pharmaceuticals ivermectin-B1a[24,25-3H] (1.85 TBq/mmol in
ethanol) and monensin [9-3H] (185 GBq/mmol) were purchased from American
Radiolabeled Company (ARC, 99% purity, Saint Louis, MO). The stock solutions were
diluted with ethanol to make working solutions (6 000 000 Bq per 1mL) before addition
to soil, and both were stored at -20⁰C.
Triplicate small jars containing 50 g of control soil each were supplemented with
approximately 10,000 dpm/g of ivermectin or monensin. Approximately 1g of soil was
taken out of the jar onto a foil boat and prepared pharmaceutical solution was added to it.
The soil was left for 10 min to allow the solvent to evaporate and mechanically mixed
with the rest of the soil. Small jars containing spiked soil were placed inside mason jars
and incubated at 30⁰C for 50 days. Microcosms contained a vial of water, but no alkali
trap, because no radiolabeled CO2 was emitted (tritium compounds do not contain
radiolabel 14C).
Subsamples (5g of soil) were taken from microcosms on days 1, 3, 7, 21, 35 and
50, and extracted with methanol three times. Briefly, 15ml of methanol (HPLC grade,
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Caledon, USA) was added to each 5g sample, shaken for 30 min and centrifuged for 10
min at 13 000 rpm (Labofuge 6000, Heraeuz Christ) and poured through a filtered funnel
(0.2 mm). This was repeated two more times. Following the third extraction, the filtrate
was evaporated under a stream of nitrogen gas, re-suspended in methanol and a
subsample of this preparation was added to 10ml of cocktail and counted using LS 6500
Multi-purpose Scintillation Counter (Beckman Instruments, Irvine, CA, USA). The
generated data were fitted to first order kinetics curve and used to estimate the half-lives
(time needed for 50% of added substance to dissipate) of the pharmaceuticals.
Radiolabeled zinc bacitracin was not available; therefore 100 mg/kg of unlabeled
ZBAC (bacitracin zinc salt, 99% pure, Sigma-Aldrich, Toronto) was added to soil,
incubated, extracted and analyzed as described above. ZBAC amended soils were
extracted with multiple solvents (Table 6), and analyzed using LC-MS/MS. However the
amount of zinc bacitracin in the samples was below detection. A follow-up experiment
revealed poor solubility of the pharmaceutical in all of the solvents used except the
phosphate buffer. Zinc bacitracin was suspended in this buffer at 2 and 10 ppm and left in
for 3 h, and the pharmaceutical was analyzed to confirm that ZBAC could be detected
through the LC-MS/MS method. LC-MS analysis was performed on a Thermo QExactive coupled to an Agilent 1290 HPLC system. Samples were run in full scan mode
to monitor for the parent ion in addition to the use of the MS/MS data for quantification.
Samples were separated using an Agilent Zorbax eclipse plup C18 RPHD column (2.1 x
50mm, 1.8 micron) using a water:acetonitrile gradient of 100 to 0 over 5 min at a flow
rate of 0.3ml/min. The MS parameters were as follows: mass range 100-1000; 35000
resolution; sheath gas 25; aux gas 15; spray voltage 4.3; capillary temperature 260 °C;
aux gas 425 °C.

2.7. Data analysis

All analysis and graphs were done using SigmaPlot (Version 10, Systat Software
Inc., Chicago, IL). Nitrification rates were estimated on the basis of N accumulated as
nitrate over the 28-day incubation and calculated as the rate of accumulation per day of
incubation. Significant differences were established at a significance level of P < 0.05
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using one way ANOVAs with Holm-Sidak post hoc tests. If data was violating the
normality or equal variance assumptions of the ANOVA test, a log transformation was
conducted. For data that were not parametric after log transformation, Kruskal-Wallis
ANOVAs on ranks were performed followed by Dunn’s post hoc tests.
The amoA or 16S gene abundance was calculated as the copy number of archaeal
amoA, bacterial amoA, or 16S rDNA per g soil (wet weight). Statistically significant
differences were designated as P < 0.05 using SigmaPlot software (as above) using one
way ANOVAs with Holm-Sidak post hoc tests. Non-parametric data was log
transformed, but if the transformation did not improve the variance or normality,
Kruskal-Wallis ANOVAs on ranks with Dunn’s post hoc tests were performed.
The intensity of the DGGE bands was not considered as a potential response to
the treatments, because of an artifact of PCR procedure, that can unequally overestimate
the high abundance sequences and underestimate or exclude the low abundance
sequences. Therefore only presence/absence of bands was considered to assess changes in
AO community structure.
The resulting sequences were analyzed using BioEdit Sequence Alignment Editor
(Hall, 1999) and run through the BLAST online search engine to identify the fragments.
The sequence data were then aligned with ClustalW method using MEGA6 (version
6.0.5, Tamura 2013). Relationships between sequences were visualized as a phylogenetic
tree.

26
3. Results

3.1. Long term field experiment

3.1.1.

Functional responses

The mineraliztion experiment with bait lamina, conducted six months after the
2013 pharmaceutical addition, showed no significant differences in activity of
macroorganisms compared to control (Figure 2). Similatily, no differences

in

mineralization using radioactiverye were observed at any of the four (fall, D0, D7, and
D30) sampling times (Table 5).
There was no significant short term effect on nitrification potential (compared to
control soil) after the fourth annual application (D7 and D30) or six months after 3 annual
applications (fall) of each pharmaceutical used singly or in mixture at either of the two
concentrations (0.1mg/kg and 10mg/kg); however, at D0 (prior to 2013 pharmaceutical
application, and year after last pharmaceutical addition) the mixture at 10 mg/kg
concentration increased the nitrification rate (F = 3.4, df = 8, 31, P<0.05; Table 4).
The ammonium concentration in field soil was low (Table 6) and it rapidly
depleted during the microcosm incubations, reaching the baseline level (0.1 μg N/g soil)
within 1-3 days (Appendix 7). The amount of ammonia was significantly higher in 10
mg/kg ZBAC and MIX treatments seven days after drug addition (H = 22.7, df = 8, 10,
P<0.05). However the correlation between the nitrification rate and initial ammonia
concentrations was not significant (Figure 3).

3.1.2.

Abundance of total bacteria (qPCR) and community structure

(DGGE)

There were no differences between the quantities of total bacteria under the
different pharmaceutical treatments compared to the control soils at any sampling points
(Figure 4). The structure of the community as per thr DGGE banding pattern also
revealed no changes in structure (Appendix 1).
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Table 4. Mean potential nitrification rate (± SD) in soils treated with different concentrations of ivermectin (IVER), monensin
(MON), zinc bacitracin (ZBAC), and mixture of the 3 (MIX) and incubated for 28 days. For laboratory experiment (100 mg/kg) N=3
for control and treatment, for field experiment (0.1 and 10 mg/kg) N control = 8, Ntreatment = 4.
Treatment
concentration pharmaceutical
0 mg/kg
CONT
IVER
MON
100 mg/kg
ZBAC
MIX
0 mg/kg
CONT
IVER
MON
10 mg/kg
ZBAC
MIX
IVER
MON
0.1 mg/kg
ZBAC
MIX

186
192
281
462
720
771
731
759
855
866
749
548
561
756

Potential nitrification rate (ng of nitrate + nitrite N accumulated/gram soil/day)
Days post pharmaceutical application
7
30
180
360
± 20
870 ± 125
N/A
N/A
± 44
910 ± 18
N/A
N/A
± 18
724 ± 32
N/A
N/A
± 157*
1038 ± 67
N/A
N/A
± 33*
948 ± 67
N/A
N/A
± 191
412 ± 72
680 ±
296
622 ±
± 31
485 ± 33
610 ±
72
785 ±
± 129
403 ± 30
571 ±
115
761 ±
± 167
476 ± 30
541 ±
228
751 ±
± 75
447 ± 59
485 ±
331
1037 ±
± 45
410 ± 45
610 ±
24
576 ±
± 209
369 ± 55
544 ±
113
662 ±
± 135
431 ± 126
549 ±
79
809 ±
± 223
405 ± 30
660 ±
156
803 ±

157
232
150
69
231*
131
178
159
268

Note: Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil. N/A means the samples
were not analysed at that time point. 180 and 360 days corresponds to “fall” and “D0”
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Bait eaten (proportion of bait gone/treatment)

Activity (proportion bait removed/treatment)

0.7

0.6

0.5

0.4

0.3

0.2

0.1

0.0
CONTROL IVER L

MON L ZBAC L

MIX L

IVER H MON H ZBAC H

MIX H

Figure 2. Bait lamina strip activity (mean ± SD) in field plots six months after pharmaceutical addition ("fall") at two different
concentrations ("L" = 0.1 mg/kg; "H" = 10 mg/kg) of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the
3(MIX).Ncontrol = 8, Ntreatment = 4. No significant differences were detected
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Table 5. Mineralization (mean ± SD) in soils treated with different concentrations of ivermectin (IVER), monensin (MON), zinc
bacitracin (ZBAC), and mixture of the 3 (MIX) at the end of 28-day incubation with radioactive rye. For laboratory experiment (100
mg/kg) N=3 for control and treatment, for field experiment (0.1 and 10 mg/kg) N control = 8, Ntreatment = 4.
Treatment

concentration pharmaceutical
0 mg/kg
CONT
IVER
MON
100 mg/kg
ZBAC
MIX
0 mg/kg
CONT
IVER
MON
10 mg/kg
ZBAC
MIX
IVER
MON
0.1 mg/kg
ZBAC
MIX

36
31
33
32
26
42
36
45
33
32
41
42
34
40

7
±
±
±
±
±
±
±
±
±
±
±
±
±
±

Mineralization (% radioactivity recovered after 28 day incubation)
Days post pharmaceutical application
360 (pre30
180 (fall)
application)
7
36 ±
3
N/A
N/A
4
32 ±
3
N/A
N/A
2
28 ±
2
N/A
N/A
2
51 ±
18
N/A
N/A
3
29 ±
4
N/A
N/A
10
38 ±
10
30 ±
8
30 ±
8
3
38 ±
4
35 ±
16
27 ±
9
3
38 ±
5
47 ±
16
28 ±
4
7
42 ±
6
36 ±
7
32 ±
6
5
38 ±
3
43 ±
18
29 ±
7
1
34 ±
6
25 ±
10
30 ±
4
3
36 ±
6
27 ±
5
30 ±
4
6
34 ±
4
59 ±
12
39 ±
9
10
37 ±
8
35 ±
4
31 ±
3

Note: Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil. N/A means the
samples were not analysed at that time point. 180 and 360 days corresponds to “fall” and “D0”

30

Table 6. Ammonia (mean ± SD) detected in soil samples under different concentrations of ivermectin (IVER), monensin (MON), zinc
bacitracin (ZBAC), and mixture of the 3 (MIX) measured at the time of soil collection. For laboratory experiment (100 mg/kg) N=3
for control and treatment, for field experiment (0.1 and 10 mg/kg) N control = 8, Ntreatment = 4.
Treatment
concentration pharmaceutical
0 mg/kg
CONT
IVER
MON
100 mg/kg
ZBAC
MIX
0 mg/kg
CONT
IVER
MON
10 mg/kg
ZBAC
MIX
IVER
MON
0.1 mg/kg
ZBAC
MIX

Ammonia present in soils (ng of ammonia N /gram soil)
Days post pharmaceutical application
7
30
180
360 (pre-application)
143 ± 88
2791 ± 71
N/A
N/A
80 ± 62
2894 ± 68
N/A
N/A
3401 ± 432*
2993 ± 100
N/A
N/A
33 ± 4
2966 ± 101
N/A
N/A
6173 ± 641*
3014 ± 117
N/A
N/A
48 ± 42
429 ± 149
3650 ±
1185
1678 ±
149
160 ± 97
566 ± 58
3519 ±
443
770 ±
58
95 ± 76
537 ± 161
2730 ±
99
2470 ±
161
193 ± 31*
455 ± 294
3677 ±
501
4352 ±
294
248 ± 22*
542 ± 160
2612 ±
1562
1889 ±
160
86 ± 22
199 ± 105
3361 ±
297
500 ±
221
71 ± 38
542 ± 188
3257 ±
393
1187 ±
1181
52 ± 42
52 ± 96
3343 ±
859
474 ±
161
115 ± 42
115 ± 96
3662 ±
560
1377 ±
239

Note: Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil. N/A means the
samples were not analysed at that time point. 180 and 360 days corresponds to “fall” and “D0”
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Figure 3. Relationship between nitrification potential rate and soil ammonium concentration at the start of the assay, pooling all of the
data from the field and laboratory experiments. Indicated is the best fit linear regression, which had a coefficient of determination (r2)
of 0.106.
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Copy number of 16S (copy/ g soil)

1e+7
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IVER H
MON H
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8e+6

6e+6

4e+6

2e+6

0
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Figure 4. Abundance of 16S rDNA (mean ± SD) in field soil samples at two different concentrations ("L" = 0.1 mg/kg; "H" = 10
mg/kg) of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX).Ncontrol = 8, Ntreatment = 4. No
differences were detected.
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3.1.3.

Abundance and community structure of ammonia oxidizing

organisms

No long term effects were seen in the PCR-DGGE profiles of AOA (Appendix 3)
or AOB (Appendix 4). The DGGE banding pattern for archaea did not change after
pharmaceutical addition, but bacterial DGGE banding had some differences between
control and treatments at D30 after pharmaceutical addition. There were also changes in
amoA copy number in AOA and AOB within 30 days of the treatment with
pharmaceuticals (Figure 5 and 6). Notably, the quantity of bacterial amoA decreased
significantly 7 days after receiving any of the pharmaceuticals, or mixture, at the 10
mg/kg dose (F = 13.3, df = 8, 31, P<0.001; Figure 6), and remained significantly lower
30 days after application of ZBAC and MON at 10 mg/kg treatment (H = 25.0, df = 8,
P<0.001). The archaeal amoA vas not significantly different between control and
treatments, but increased significantly at D30 for all soils receiving 10 mg/kg (F = 11.1,
df = 8, 29, P<0.001; Figure 5). Expressed as a ratio, AOA /AOB changed from 0.25 at D0
to 0.5 at D7 and 2 at D30 with 10mg/kg pharmaceutical addition, reflecting a decrease in
AOB amoA copy numbers and a subsequent increase of AOA at D30. We saw a 5 fold
difference between AOA and AOB, with the bacteria remaining as the dominant
ammonia oxidizer.
Cloned qPCR products (3 clones from each replicate treatment) at the control and
high mixture treatment 30 days post pharmaceutical application in the field were
sequenced and revealed little diversity in archaeal or bacterial sequences (Figure 7 and 8).
The sequences did not form distinct control-only or mixture-only clades, but were
intermixed with each other.

3.2. Short term laboratory experiment

3.2.1.

Functional responses

Mineralization did not change seven or 30 days after the treatment with 100
mg/kg concentrations of the studied pharmaceuticals (Table 4). The no-change in this
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Figure 5. Archaeal amoA copy number (mean ± SD) in field soils at two different concentrations ("L" = 0.1 mg/kg; "H" = 10 mg/kg)
of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), and mixture of the 3 (MIX). Ncontrol = 8, Ntreatment = 4. Asterisks
represent treatments that were significantly different (P<0.05) from control.
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Copy of amoA genes (copy/g soil)

2e+6
CONTROL
IVER L
MON L
ZBAC L
MIX L
IVER H
MON H
ZBAC H
MIX H

2e+6

1e+6

8e+5

*
*

4e+5

0
fall

D0

D7

D30

Figure 6. Bacterial amoA copy number (mean ± SD) in field soils at two different concentrations ("L" = 0.1 mg/kg; "H" = 10 mg/kg)
of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX). Ncontrol = 8, Ntreatment = 4. Asterisks
represent treatments that were significantly different (P<0.05) from control.
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Figure 7. Relationship of archaeal amoA sequences extracted 30 days after
pharmaceutical addition in 2013 from control plot (control 1-4, marked with black
circles) and 10 mg/kg mixture (mix 1-4, marked with white circles). The scale bar
represents 0.005 nucleotide substitution per 100 nucleotides.
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Figure 8. Relationship of bacterial amoA sequences extracted 30 days after
pharmaceutical addition in 2013 from control plot (control 1-4, marked with black
circles) and 10 mg/kg mixture (mix 1-4, marked with white circles). The scale bar
represents 0.05 nucleotide substitution per 100 nucleotides.
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endpoint contrasted with the nitrification rate at 100mg/kg concentration. The
nitrification was significantly higher in ZBAC and MIX (F = 186.9, df = 4, 10, P<0.001)
seven days after the pharmaceutical addition, when compared to control. This difference
was not present at D30. Starting concentrations of ammonia present in soil 7 days after
pharmaceutical addition was significantly sigher in MON and MIX treatments (F =
176.1, d = 4, 10, P<0.001), but was depleted fast during the microcosm incubations
(Appendix 6) and no differences were detected at day 30 after pharmaceutical addition
(Table 6).

3.2.2.

Abundance and community structure of total bacteria and amoA

There was no significant difference between quantity of total bacteria under the
different treatments (Figure 9), nor was the DGGE banding pattern of 16S rDNA
different between the treatments and control (Appendix 2). Similarily, DGGE analysis of
bacterial or archaeal amoA genes showed no difference in community structure between
the treatments and the control (Appendix 5). There was no detected change in the amoA
gene copy number 30 days post-application of pharmaceuticals (Figure 10 and 11), but a
significant increase in amoA under IVER treatmnet was detected at D7 in archaeal
population (F = 4.7, df = 4, 10, P<0.001).

3.3. Pharmaceutical dissipation

The radioactive analysis of IVER and MON showed that they were degraded
within one month of application to the soil (IVER t1/2 = 15 days, MON t1/2 = 20 days).
ZBAC could not be extracted from the soils, and dissolved poorly in most of the solvents
used (methanol, ethanol. ethyl acetate, acetonitrilie). It was dissolved in potassium buffer
(what is in it), and detected at 1 and 10 mg/kg concentrations in solution, but extraction
efficiency from soil was very low (below 10% at D0). It is most likely tightly bound to
soil particles, and therefore unavailable.
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Figure 9. Abundance of 16S rDNA (mean ± SD) in laboratory soil samples at two different concentrations ("L" = 0.1 mg/kg; "H" = 10
mg/kg) of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX). No differences were detected.
Ncontrol = 3, Ntreatment = 3. No differences were detected.
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Figure 10. Abundance of archaeal amoA (mean ± SD) in soils treated with 100 mg/kg concentration of ivermectin (IVER), monensin
(MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX). Ncontrol = 3, Ntreatment = 3. Asterisks represent treatments that were
significantly different (P<0.05) from control.
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Figure 11. Abundance of bacterial amoA (mean ± SD)in soils treated with 100 mg/kg concentration of ivermectin (IVER), monensin
(MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX). Ncontrol = 3, Ntreatment = 3. No differences were detected.
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4. Discussion

The pharmaceutical concentrations of 0.1, 10, and 100 mg/kg soil were chosen to
encompass a regulatory threshold level that was relevant with respect to expected
environmental concentrations, through to excessive exposures that are expected to have
an effect. The 0.1 mg/kg concentration is a cut-off for Tier 1 assessment and is often
considered below the no observed effect concentration (NOEC), and therefore chosen as
a guideline and regulatory measure of pharmaceutical concentration. The concentration
of 10 mg/kg was considered as an effect concentration that will have an impact on
studied processes, while 100 mg/kg is very high and chosen as an inhibitory
concentration for this study.

4.1. High pharmaceutical concentration, short term exposure

Under

laboratory

conditions,

an

unrealistically

high

concentration

of

pharmaceuticals was added to the soil to achieve an effect concentration that would affect
the measured endpoints. The lab experiment increased the concentration of
pharmaceuticals 10 times from the field exposure and therefore the pharmaceutical
amount could reach stress or toxic levels able to disrupt soil processes, as shown. Short
term (up to 30 days) exposure to 100 mg/kg pharmaceuticals affected the functional
endpoints, but had little impact on 16S rDNA or amoA gene abundance.
The mixture of pharmaceuticals negatively affected mineralization of radioactive
rye at 7 days post application compared to the untreated control. This effect was not
present 30 days after pharmaceutical addition. In contrast to a negative effect on
mineralization, ZBAC and MIX treatments had a positive effect on nitrogen potential
rates 7 days after pharmaceutical addition compared to control. Both MIX and ZBAC
followed a similar pattern, indicating that zinc bacitracin present in the mixture might be
the driving force behind the mixture effect in this incubation. As with mineralization, the
effect was not seen 30 days after pharmaceutical addition, therefore the effects these
pharmaceuticals exert on soil organisms are short-lived.
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The fast return to control rates in the mineralization experiment (within 30 days of
pharmaceutical addition) can be explained by fast pharmaceutical dissipation. For
example, pharmaceuticals can be inactivated through biodegradation (microbial
breakdown), photolysis (degradation using light), or sorption to soil (attaching to soil
particles), all of which decrease pharmaceutical concentrations and limit bioavailability.
Dissipation rates (expressed as half-lives in this study) of MON were higher than
previously published values (Carlson and Mabury 2006, Sassman and Lee 2007),
however some discrepancies between half-lives have been reported. Monensin dissipation
has varied between 3 and 13 days depending on whether the experiment was carried out
in the field, or in the laboratory (Yoshida et al. 2010), with field conditions increasing the
pharmaceutical dissipation rates. In the case of ivermectin, the half-life depended on
whether the experiment was carried out in the presence of soil microorganisms and light
(Mougin et al. 2003).

IVER is photodegradable (Mougin et al. 2003), but in the dark

dissipation relies on microbial dissipation only, and is much slower (21 days compared to
230 days). The half-life of 15 days found here for IVER was shorter than those
previously reported (Mougin et al. 2003, Levot 2011). Other factors such as presence of
manure (Al-Rajab et al. 2009), depth in the soil column (Santoro et al., 2008), or soil type
(Sabourin et al., 2010) were considered as potential sources of variation on
pharmaceutical dissipation in the environment. Soil sorption can also be a reason a
particular pharmaceutical is removed from the soil quickly after its addition, decreasing
the estimated half-life. However sorption to soil does not always reduce bioavailability
(Ingerslev and Halling-Sorensen 2000, Thiele-Bruhn 2003). It was shown that adding 20
mg/kg of ciprofloxacin to soil did not inhibit the mineralization function, because up to
88% of the pharmaceutical was strongly bound to soil (Girardi et al. 2011). Here, ZBAC
was strongly attached to soil and assumed to be unavailable to microorganisms, while a
high recorded extraction rate from faeces (92-93%) was previously reported (Donoso et
al. 1970, Wicker et al. 1977, Frøyshov et al. 1986). ZBAC was not soluble in tested
solvents, and only soluble in phosphate buffer at low concentration, therefore its half-life
could not have been determined. Because the studied pharmaceuticals dissipate rapidly in
soils (Sarmah et al. 2006, Liebig et al. 2010a), they are active against microorganisms for
only a short time. Their negative effects were seen at the 100 mg/kg concentration,
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showing that they are capable of inhibiting microbial processes if added to soil at high
enough levels.
Another reason for changes in nitrification occurring at day 7 but not day 30 after
pharmaceutical addition was nitrogen depletion in the soil. Ammonium levels were very
low at the start of the experiment, and other sources of nitrogen had to be available for
the increased nitrification rate. Antimicrobial bacitracin added to the soil could have
dissociated from the zinc bacitracin complex and negatively affected sensitive groups of
microorganisms and released ammonium, which increased the nitrification. Another
possibility is that heavy metal zinc killed sensitive organisms in soil. Heavy metals can
select for tolerant species at the expense of sensitive species, resulting in pollution
induced community tolerance (Schmitt et al. 2006, Fechner et al. 2011). The soil used in
the experiments had 4.6-5.5 mg Zn/kg soil (A&L Canada Laboratories Inc., Soil test
report, 2012) in the absence of ZBAC addition. The 100 mg/kg treatment doubled the
concentration of zinc in soils (adding approximately 4.4 mg of zinc per kg soil). Prior
exposure to zinc heavy metal (between 30 and 780 mg/kg) has improved rather than
diminished nitrification in soil (Rusk et al. 2004), while Mertens et al. (2009) showed that
nitrification is restored to control levels in soil within 2 years of zinc contamination. The
organisms living in the experimental soil might therefore already have been tolerant to
zinc prior to the treatment, and thus experienced no negative effect after pharmaceutical
addition. Initial amount of ammonium in the soil did not correlate well with the increase
in nitrification rates, and no change in abundance was detected. Therefore, it appears that
zinc and bacitracin were unlikely to increase soil ammonium-N by killing sensitive
organisms.
Another possible reason for the stimulation of nitrification by ZBAC was that
ZBAC carried sufficient N to increase the nitrification rate. As the only pharmaceutical
that contained N (16% of compound by MW), it might have stimulated nitrification.
However, this was unlikely since initial ammonium concentrations were not correlated
with nitrification rates, indicating that ammonium-N was not rate limiting in the assay.
Certain microorganisms are able to grow on pharmaceuticals, as was found with under
long-term application of sulfamethazine (Topp et al. 2013).
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The decrease in mineralization and increase in nitrification was not accompanied
by changes in community structure for the 100 mg/kg treatments based on DGGE
banding profiles using 16S rDNA gene primers, or 16S rDNA gene abundance measured
by quantitative PCR. Similarly, no differences in bacterial amoA gene copies were seen at
the concentration of 100 mg/kg at 7 or 30 days after pharmaceutical addition, despite
observed changes in mineralization and nitrification rates. In a study by Ollivier et al.
(2013), a single application of sulfamethazine contaminated manure on a field did not
result in great changes in AOA or AOB abundance, but the second application caused a
15-fold increase in AOA abundance compared to AOB (Ollivier et al. 2013). Therefore a
multiyear contamination with 100mg/kg of the studied pharmaceuticals might result in
changed amoA abundance. However, this high concentration of pharmaceuticals is highly
unrealistic in the environment.
Pharmaceutical concentrations found in the field vary with pharmaceutical type,
persistence and the quantities used in animal productions. For example, topsoil fertilized
with poultry litter from commercial farms contained 5-183 µg monensin/kg soil (Sun et
al. 2013). A cumulative PECsoil of 63.4 µg monensin/kg was derived for soil receiving six
consecutive applications of manure (Hansen et al. 2009) and 50 µg monensin/kg
following a single application of poultry litter (Žižek et al. 2011). In a study undertaken
in Nebraska, liquid swine manure contained 320 + 31 mg bacitracin A /kg dry weight
(Joy et al. 2014). Manure from a pig finishing operation in China contained 51 + 2.3 mg
bacitracin/kg dry weight (Zhou et al. 2013). In both instances no residues were detected
in soils treated with these manures, suggesting that ZBAC was sequestered or dissipated.
Ivermectin can be delivered through injection, pour on and oral drench (Lumaret et al.
2012). Ivermectin-treated cattle excreted 0.31 to 0.81 mg ivermectin/kg dung dry weight,
and pasture soil immediately under dung pats had ivermectin concentrations of up to
0.085 mg/kg soil dry weight (Römbke et al. 2010). Liebig et al. (2010b) derived a steady
state (considering dissipation rate and manure application practice) PEC soil of 2.67-6.22
µg ivermectin/kg soil dry weight for soil receiving manure from weaner pigs (Liebig et
al. 2010b). Similar to pharmaceuticals, heavy metals can also cause change in community
composition and microorganism abundance. Under the 100 mg/kg treatment, the soil
received about 4.4 mg/kg of zinc metal.
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Laboratory additions

of

100

mg/kg increased

the

concentration

of

pharmaceuticals, changing functional endpoints in soil, therefore validating that these
pharmaceuticals can cause a negative effect in soils. The change in function was not,
however, accompanied by changes in 16S rDNA or amoA gene abundance. The
difference seen could be attributed to the soils being treated with a single application of
pharmaceuticals, as opposed to the multi-year exposure present in the field. After
pharmaceutical addition, the soil was incubated in the laboratory at a constant
temperature, and not exposed to the temperature fluctuations that are present outside
(Tourna et al. 2008), nor changing day/night cycles, or other environmental factors, like
rain or frost. Therefore studying toxicity of pharmaceuticals under field conditions needs
to be considered.

4.2. Intermediate levels of pharmaceuticals

At the intermediate field exposure dose of 10 mg/kg, there was no long term (as
evaluated in 2012-2013 using pre-application samples) effect on measured endpoints for
single pharmaceutical exposures, signifying that this level pharmaceutical exposure over
3 seasons did not disturb soil nitrification. Mixture exposure increased the nitrification
rate over the long term (one year after application), but not the short term (within 30 days
of pharmaceutical application). Both the bait lamina study and the radioactive rye
mineralization experiments showed that single pharmaceuticals or mixture had no
significant effects on mineralization. These two mineralization experiments tested the
same soil, but due to soil preparation (moisture adjustment and sieving) prior to the
radioactive rye addition, some soil dwelling organisms were excluded from that
experiment. Specifically, bait lamina strips added to the field soil were exposed to micro, meso- and macroorganisms, while the rye incubation soil was sieved to a maximum
particle size of 2 mm. Therefore the mixture might have had small negative effects on
soil macroorganisms, but not on meso- or microorganisms. Short term (within 30 days of
addition) effects of 10mg/kg pharmaceutical addition to soil did not change the functions
measured or 16S rDNA gene abundance, but relative abundance of the amoA gene for
ammonia oxidizing archaea and bacteria changed. Similarly, it was found that tylosin at
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10 mg/L changed the structure of the bacterial community, but did not change the
denitrification rate (Roose-Amsaleg et al. 2013), while a shift in community composition
and a decreased rate of substrate mineralization was detected for tylosin at 50 mg/kg
(Demoling and Baath 2008). When looking at the responses of agricultural soil
microorganisms to sulfachloropyridazine, a concentration of only 7.3 mg/kg resulted in
changes in community composition due to sensitive organisms being replaced by tolerant
species (Schmitt et al. 2004).
The difference in the ratio of archaeal to bacterial amoA genes in soils receiving
any of the pharmaceuticals or mixture at 10 mg/kg was reflective of both an increase in
AOA abundance (30 days after addition) and decrease in AOB abundance (both 7 and 30
days after addition). AOB abundance decreased at 7 days post pharmaceutical addition,
while AOA remained unchanged. The decrease in the abundance of ammonia-oxidizing
bacteria at D7 with exposure to 10mg/kg, suggests these concentrations were toxic to AO
bacteria. Because AOA grows faster than AOB (You et al. 2009), bacteria would be at a
disadvantage. Higher observed susceptibility of AOB to pharmaceuticals compared to
AOA could be due to structural differences between the two groups. Unlike bacterial cell
walls, archaeal cell walls do not have peptidoglycan present (Schleper and Nicol 2010),
and these peptidoglycans are a target for many pharmaceuticals (Khelaifia and Drancourt
2012). Therefore AOA would be less susceptible to a number of pharmaceuticals. Other
factors such as light intensity (Merbt et al. 2012), or soil acidity (Gubry-Rangin et al.
2011) were shown to influence AO archaea. Merbt et al. (2012) showed that under
constant light (60μE/m2/s), AOA growth was more sensitive that AOB growth, and
cycles of light and dark were needed for recovery. The molecular analysis of
representative archaea from soil samples showed clustering into pH dependent clusters,
where adaptation to different pH was evident (Gubry-Rangin et al. 2011). However in
present study, the sequences from mixture and control soils did not form distinct
clustering, but rather the sequences were intermixed suggesting that the community
under 10 mg/kg concentration of the mixture did not result in community shift.
Another possibility for a decrease in AOB abundance is limited NH4+, which
prevents AOB from further growth. The initial growth of ammonia oxidizing bacteria
would decrease the available ammonium in soil, making the environment less favorable
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for that group. By day 7 after pharmaceutical addition the amount of extractable
ammonium in field soils decreased below the limit of detection. Lower nitrogen resources
would mean AOB numbers would diminish quickly, while the space and released
nutrients would be available to archaea. AOA have a competitive advantage in nitrogen
limited environments (Km= 0.132 μM NH4+; Martens-Habbena et al. 2009), and often a
decreasing amount of ammonium corresponds to increasing AOA abundance (Sauder et
al. 2012), as opposed to high ammonium sites where AOB (Km= 15 μM NH4+; MartensHabbena et al. 2009) has an advantage (Verhamme et al. 2011). It was noted in multiple
studies that agricultural soils that receive inorganic N in the form of fertilizer have higher
abundance of AOB organisms due to nitrogen rich manure addition (Glaser et al. 2010,
Höfferle et al. 2010, Reed et al. 2010). Similarly, soil used for cattle overwintering with
heavy animal presence had increased abundance of AOB (Radl et al. 2014).
With low amounts of N in soil, AOB numbers remained low and the AOA
numbers increased, presumably due to their ability to thrive in low nitrogen environments
and utilizing the space released by AOB. The functional redundancy of ammonia
oxidizing organisms (discussed in Nannipieri et al. 2003) allowed for retained function in
the soil at 10 mg/kg, despite changing numbers of AOA and AOB, as detected by
quantitative PCR of the amoA gene.

4.3. Regulatory threshold concentrations

There were no effects of any treatment, either long term (after 3 years of
applications) or acute (7 and 30 days after application), for the environmentally relevant
and regulatory concentration of 0.1 mg/kg on any measured functional endpoints. This
held true for both single pharmaceutical and mixture exposures.
Pharmaceuticals were most likely applied at sub-inhibitory concentrations
(NOEC) that did not affect microbial populations, even for the mixture treatment. This
result could be a side effect of existing resistance pathways, or tolerance mechanisms.
Natural tolerance to naturally derived antibiotics exists in soils (Thiele-Bruhn 2003,
D'Costa et al. 2011), especially for soil-derived chemicals. For example, some botanically
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derived pesticides have no effect on microorganisms, as opposed to synthetics that were
not derived from nature but created in laboratory (Spyrou et al. 2009).
The threshold concentration of 0.1 mg/kg, the cut off for Environmental Risk
Assessments, is conservative enough not to disrupt soil processes or cause any detectable
changes in amoA gene abundance or community structure of soil organisms under IVER,
MON and ZBAC treatments. Based on the current study, the three studied
pharmaceuticals were dissipated in the soils rapidly, but other pharmaceuticals can be
persistent in the environment, and accumulate over the years of exposure (Tamtam et al.
2011, Vazquez-Roig et al. 2012). Therefore, long term dissipation studies of different
pharmaceuticals in the field should always be carried out, and lab experiments might
underestimate the long term effect pharmaceuticals can have on soil organisms.
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Conclusion

At an environmentally reasonable and regulatory threshold concentration of 0.1
mg/kg, there was no effect of the studied pharmaceuticals on mineralization or
nitrification, either in the long or short term. This scenario, however, was tested on an
artificial system, where pharmaceuticals were added to the soil directly in order to control
the concentrations. Using manure mixed with pharmaceuticals is needed to verify that
this would happen during normal farming practice.
Manure acts as a source of nutrients to soil microorganisms and it has sorption
characteristics (it can bind the pharmaceuticals to the organic matter present in the
manure) that can make pharmaceuticals bio-unavailable. Therefore adding veterinary
pharmaceuticals with the manure would potentially decrease any negative effects
observed in this study. However, number of different pharmaceuticals can be added to the
soil at once with each manure application, due to multiple veterinary pharmaceuticals
used in animal production. The mixture of these pharmaceuticals can affect the soil
microorganisms, where single drug did not. Therefore it is important to measure
additional endpoints that were beyond the scope of this study. One could look at other
soil functions (other steps in nitrogen cycle in the soil, or other nutrient cycling), or
biodiversity (displacement of species, direct counts or molecular analysis) to assess if the
pharmaceuticals affect other groups of microorganisms or their function.
It is possible that if our mixture contained more than the 3 studied
pharmaceuticals at 0.1 mg/kg concentration, it could have an impact on studied functions
and abundance of ammonia oxidizers, especially bacteria. It is unknown if ammonia
oxidizing archaea would at all respond to the veterinary pharmaceuticals. Little is known
about that group in soil; further study of archaeal physiology from soil-isolated
microorganisms is needed to understand how they interact with pharmaceuticals in the
environment. It is essential to get more information about the soil dwelling organisms,
their function, and how that function in soils is affected by addition of manure containing
veterinary pharmaceutical.
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Appendix 1. DGGE images using 16S rDNA primers at D0 (A), D7 (B), D30 (C) and
fall (D) after field pharmaceutical addition. Line 1 represents the control, lines 2-5
represent 0.1 mg/kg treatments, and lines 6-9 represent 10 mg/kg treatments. Treatments
are: 2 , 6 = ivermectin;, 3, 7 = monensin; 4, 8 = zinc bacitracin; 5, 10 = mixture.
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Appendix 2. DGGE image using 16S rDNA primers and soils treated with
pharmaceuticals at 100 mg/kg. Images represent soils at D7 (lines 1-5) or D30 (lines 610). Treatments are as follows: 1, 6 = control; 2, 7 = ivermectin; 3, 8 = monensin; 4, 9 =
zinc bacitracin; 5, 10 = mixture.
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Appendix 3. DGGE images obtained using archaeal amoA primers at D0 (A), D7 (B),
D30 (C) and fall (D) after field pharmaceutical addition. Line 1 represents the control,
lines 2-5 represent 0.1 mg/kg treatments, and lines 6-9 represent 10 mg/kg treatments.
Treatments are: 2, 6 = ivermectin; 3, 7 = monensin; 4, 8 = zinc bacitracin; 5, 10 =
mixture.
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Appendix 4. DGGE images obtained using bacterial amoA primers at D0 (A), D7 (B),
D30 (C) and fall (D) after field pharmaceutical addition. Line 1 represents the control,
lines 2-5 represent 0.1 mg/kg treatments, and lines 6-9 represent 10 mg/kg treatments.
Treatments are: 2, 6 = ivermectin; 3, 7 = monensin; 4, 8 = zinc bacitracin; 5, 10 =
mixture.
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Appendix 5. DGGE image obtained using archaeal (A) and bacterial (B) amoA, and soils
treated with 100 mg/kg of pharmaceuticals. Lines 1-5 represent D7 soil, and lines 6-10
represent D30 soil. 1, 6 = control, 2, 7 = ivermectin, 3, 8 = monensin, 4, 9 = zinc
bacitracin, 5, 10 = mixture.
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D7 soil

D7 soil

D30 soil

D30 soil

Appendix 6. Nitrification potential experiments with soils treated with 100 mg/kg of
pharmaceuticals. Panels A and B show ammonia utilization, and panels C and D show
nitrate accumulation.
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Appendix 7. Nitrification potential experiments in soil treated with 0.1 mg/kg (“L”) or
10 mg/kg (“H”) of pharmaceuticals. Panels A, B and C represent ammonia utilization,
while panels D, E and F represent nitrate accumulation.
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Appendix 8. Summary of performed statistics.

field

experiment type
mineralization

bait lamina
nitrification

Ammonia, initial
concentration

archaeal amoA
abundance

bacterial amoA
abundance

laboratory

mineralization
nitrification
Ammonia, initial
concentration

sampling
time
fall
D0
D7
D30
fall
fall
D0
D7
D30
fall
D0
D7
D30
fall
D0
D7
D30
fall
D0
D7
D30
D7
D30
D7
D30

F stat
1.79
1.05
0.26
1.59
3.38

2.88

1.85
1.14
11.10
1.23
1.11
20.33
8.62
0.84
2.74
186.92

ANOVA
P
df
value
8, 29
0.12
8, 30
0.42
8, 29
8, 31
8, 31

8, 29

8, 31
8, 31
8, 30
8, 30
8, 28
8,30
8, 30
4, 10
4, 10
4, 10

0.97
0.17
0.01

0.02

0.11
0.37
0.02
0.32
0.39
<0.001
<0.001
0.53
0.09
<0.001

HolmSidak
ns
ns

Kruskal-Wallis ANOVA on ranks
H
p
Dunn's
stat df value
Method

11.76

8

0.16

ns

3.52

8

0.90

ns

8.28
12.09
15.07

8
8
8

0.41
0.15
0.06

ns
ns
ns

22.75
10.48

8
8

<0.05
0.23

*
ns

14.79

8

0.06

ns

18.90

4

0.03

*

ns
ns
*

ns

ns
ns
*
ns
ns
*
*
ns
ns
*

archaeal amoA
abundance

D7
D30
D7
D30

176.10
1.78
4.71
5.62

4, 10
4, 10
4, 10
4, 10

<0.001
0.21
<0.001
0.01

*
ns
*
*

bacterial amoA
abundance

D7
D30

0.69
3.56

4,10
4, 10

0.62
0.05

ns
ns

Note. Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil; ns
means there was no significant differences between treatment and controls.
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